Neurocrine Biosciences
NBIX
#1220
Rank
A$24.21 B
Marketcap
$239.15
Share price
-0.46%
Change (1 day)
9.23%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company